ONC Share Price

Open 0.34 Change Price %
High 0.37 1 Day 0.01 2.94
Low 0.33 1 Week 0.03 9.38
Close 0.35 1 Month 0.07 25.00
Volume 133973 1 Year -0.05 -12.50
52 Week High 0.75
52 Week Low 0.19
ONC Important Levels
Resistance 2 0.39
Resistance 1 0.37
Pivot 0.35
Support 1 0.33
Support 2 0.31
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
YRI 4.04 -10.02%
TBE 0.03 0.00%
CPG 16.24 7.76%
CPG 16.24 7.76%
FM 15.00 -5.48%
More..
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
KOR 0.93 20.78%
KOR 0.93 20.78%
KAT 0.48 17.07%
KAT 0.48 17.07%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
YRB-A 0.08 -11.11%
YRI 4.04 -10.02%
S 1.18 -9.92%
S 1.18 -9.92%
CTU-A 0.19 -9.52%
BEI-UN 45.62 -6.69%
DEJ 0.14 -6.67%
DEJ 0.14 -6.67%
PLS 1.17 -6.40%
More..

Oncolytics Biotech Inc (TSE: ONC)

ONC Technical Analysis 2
As on 17th Feb 2017 ONC Share Price closed @ 0.35 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.39 & Strong Buy for SHORT-TERM with Stoploss of 0.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
ONC Target for February
1st Target up-side 0.29
2nd Target up-side 0.31
3rd Target up-side 0.33
1st Target down-side 0.23
2nd Target down-side 0.21
3rd Target down-side 0.19
ONC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.oncolyticsbiotech.com
ONC Address
ONC
1167 Kensington Crescent NW
Suite 210
Calgary, AB T2N 1X7
Canada
Phone: 403-670-7377
Fax: 403-283-0858
ONC Latest News
Should You Buy Or Sell Oncolytics Biotech, Inc. (ONCY) On Analyst Concensus?   NewsDen   - 16th Feb 17
Oncolytics Biotech, Inc. (ONCY) Reviewed By Analysts   The De Soto Edge   - 04th Feb 17
Oncolytics Biotech® Inc. Announces Management Team Changes   Canada NewsWire (press release)   - 03rd Nov 16
Oncolytics Biotech® Inc. Reports Additional Data from Randomized Phase II ...   PR Newswire (press release)   - 10th Aug 16
Where Can Oncolytics Go After Dismal ASCO Results?   Seeking Alpha   - 20th May 16
Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II ...   PR Newswire (press release)   - 19th May 16
GOG Sends Rebuttal Letter to Oncolytics Biotech   The Cancer Letter Publications   - 03rd May 16
Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Receipt ...   Smarter Analyst   - 29th Oct 15
Oncolytics: Killing Cancer With A Virus   Seeking Alpha   - 20th Jul 15
On the Reversal: Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)   MicroCap Daily   - 10th Feb 15
Interactive Technical Analysis Chart Oncolytics Biotech Inc ( ONC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oncolytics Biotech Inc
ONC Business Profile
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic. Its cancer product is a potential therapeutic for tumours possessing an activated Ras pathway. The company was founded in 1998 and is headquartered in Calgary, Canada.